This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Critical Care/ Intensive Care Medicine  • Adult Critical Care  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As a Course Director for Advance Cardiac Life Support (ACLS) classes, I read with interest the meta-analysis by Aung and Htay^1(p23) regarding vasopressin in the treatment of cardiac arrest. They conclude that although vasopressin "may be at least equivalent to epinephrine,"^1(p23) guidelines "should not recommend vasopressin in resuscitation protocols."^1(p17) Their primary objection to the use of vasopressin appears to be one of cost.

The authors state that the cost of 1 dose of vasopressin is 15 times the cost of 1 dose of epinephrine.² I would take issue with this cost evaluation on 2 points. Since the publication of their source reference for price, the cost of vasopressin has decreased considerably. Our hospital pharmacy reports that the current cost for a 40-unit dose of vasopressin is $2.40, while the cost for a 1-mg dose of epinephrine is $1.44. This would make the current cost of vasopressin per dose less than . . . [Full Text of this Article]

AUTHOR INFORMATION
Daniel D. Buff, MD, CNSP

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Vasopressin for Cardiac Arrest: A Systematic Review and Meta-analysis
KoKo Aung and Thwe Htay
Arch Intern Med. 2005;165(1):17-24.
ABSTRACT | FULL TEXT